BCR and B-cell chronic lymphocytic leukemia: In contrast, the finding of a significantly earlier CLL incidence of mainly the non-VH11 type in IgH.TEμ.Siglec-G−/− and IgH.TEμ.E-Btk-2 mice suggests that BCR signaling thresholds are a key factor in determining CLL disease course.